{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T01:54:24Z","timestamp":1777686864199,"version":"3.51.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001509","name":"Royal Society Te Ap\u0101rangi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001509","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmcd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.numecd.2025.104280","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T00:42:10Z","timestamp":1755650530000},"page":"104280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Interplay between intra-pancreatic fat deposition, exchangeable apolipoproteins, and lipoprotein subclasses"],"prefix":"10.1016","volume":"36","author":[{"given":"Yutong","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juyeon","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Loren","family":"Skudder-Hill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiatiguli","family":"Shamaitijiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana R.","family":"Sequeira-Bisson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5923-9062","authenticated-orcid":false,"given":"Maxim S.","family":"Petrov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.numecd.2025.104280_bib1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.numecd.2025.104280_bib2","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/eurheartj\/ehr112","article-title":"Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management","volume":"32","author":"Chapman","year":"2011","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.numecd.2025.104280_bib3","doi-asserted-by":"crossref","first-page":"s41","DOI":"10.7861\/clinmedicine.14-6-s41","article-title":"Dyslipidaemia: what's around the corner?","volume":"14","author":"Wierzbicki","year":"2014","journal-title":"Clin Med"},{"issue":"11","key":"10.1016\/j.numecd.2025.104280_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s12170-022-00702-1","article-title":"Triglyceride-rich lipoproteins, remnants, and atherosclerotic cardiovascular disease risk","volume":"16","author":"Bharadiya","year":"2022","journal-title":"Curr Cardiovasc Risk Rep"},{"issue":"6","key":"10.1016\/j.numecd.2025.104280_bib5","doi-asserted-by":"crossref","first-page":"A20","DOI":"10.1016\/0002-9149(90)90565-I","article-title":"Interrelationship of triglycerides with lipoproteins and high-density lipoproteins","volume":"66","author":"Gotto","year":"1990","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.numecd.2025.104280_bib6","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1373\/clinchem.2014.234146","article-title":"Extreme nonfasting remnant cholesterol vs extreme LDL cholesterol as contributors to cardiovascular disease and all-cause mortality in 90000 individuals from the general population","volume":"61","author":"Varbo","year":"2015","journal-title":"Clin Chem"},{"issue":"39","key":"10.1016\/j.numecd.2025.104280_bib7","doi-asserted-by":"crossref","first-page":"4186","DOI":"10.1093\/eurheartj\/ehad337","article-title":"Triglyceride-rich lipoprotein remnants, low-density lipoproteins, and risk of coronary heart disease: a UK biobank study","volume":"44","author":"Bj\u00f6rnson","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.numecd.2025.104280_bib8","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2020.04.015","article-title":"High density lipoprotein functionality and cardiovascular events and mortality: a systematic review and meta-analysis","volume":"302","author":"Soria-Florido","year":"2020","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.numecd.2025.104280_bib9","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0021-9150(00)00603-1","article-title":"HDL-cholesterol as a marker of coronary heart disease risk: the qu\u00e9bec cardiovascular study","volume":"153","author":"Despr\u00e9s","year":"2000","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2025.104280_bib10","first-page":"20","article-title":"Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease","volume":"102","year":"2000","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.numecd.2025.104280_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13914","article-title":"Relationship of fat in the pancreas with cardiovascular disease: a systematic review and meta-analysis","volume":"26","author":"Zhang","year":"2025","journal-title":"Obes Rev"},{"issue":"11","key":"10.1016\/j.numecd.2025.104280_bib12","doi-asserted-by":"crossref","first-page":"102881","DOI":"10.1016\/j.dsx.2023.102881","article-title":"Comprehensive analysis of dyslipidemia states associated with fat in the pancreas","volume":"17","author":"Skudder-Hill","year":"2023","journal-title":"Diabetes Metab Syndr"},{"issue":"15","key":"10.1016\/j.numecd.2025.104280_bib13","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3748\/wjg.15.1869","article-title":"Clinical implications of fatty pancreas: correlations between fatty pancreas and metabolic syndrome","volume":"15","author":"Lee","year":"2009","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.numecd.2025.104280_bib14","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1111\/dom.15233","article-title":"Remnant cholesterol, but not low\u2010density lipoprotein cholesterol, is associated with intra\u2010pancreatic fat deposition","volume":"25","author":"Skudder\u2010Hill","year":"2023","journal-title":"Diabetes Obes Metabol"},{"issue":"8","key":"10.1016\/j.numecd.2025.104280_bib15","doi-asserted-by":"crossref","first-page":"e2918","DOI":"10.1002\/dmrr.2918","article-title":"Ectopic fat accumulation in the pancreas and its biomarkers: a systematic review and meta\u2010analysis","volume":"33","author":"Singh","year":"2017","journal-title":"DiabetesMetab Res Rev"},{"issue":"6","key":"10.1016\/j.numecd.2025.104280_bib16","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1111\/dom.16338","article-title":"Associations of intra-pancreatic fat deposition with triglyceride-rich lipoproteins and lipoprotein lipase","volume":"27","author":"Liu","year":"2025","journal-title":"Diabetes Obes Metabol"},{"issue":"1","key":"10.1016\/j.numecd.2025.104280_bib17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/dom.15990","article-title":"Relationship of high-density lipoprotein subfractions and apolipoprotein A-I with fat in the pancreas","volume":"27","author":"Liu","year":"2025","journal-title":"Diabetes Obes Metabol"},{"key":"10.1016\/j.numecd.2025.104280_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2017.10.025","article-title":"Apolipoprotein C-II: new findings related to genetics, biochemistry, and role in triglyceride metabolism","volume":"267","author":"Wolska","year":"2017","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.numecd.2025.104280_bib19","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.cca.2020.01.015","article-title":"The exchangeable apolipoproteins in lipid metabolism and obesity","volume":"503","author":"Su","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.numecd.2025.104280_bib20","doi-asserted-by":"crossref","first-page":"100475","DOI":"10.1016\/j.jlr.2023.100475","article-title":"Apolipoprotein C3: form begets function","volume":"65","author":"Bornfeldt","year":"2024","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.numecd.2025.104280_bib21","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1021\/bi0267184","article-title":"Global structure and dynamics of human apolipoprotein CII in complex with micelles: evidence for increased mobility of the helix involved in the activation of lipoprotein lipase","volume":"42","author":"Zdunek","year":"2003","journal-title":"Biochemistry (Easton)"},{"issue":"9","key":"10.1016\/j.numecd.2025.104280_bib22","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1194\/jlr.M078220","article-title":"Apolipoprotein C-III inhibits triglyceride hydrolysis by GPIHBP1-bound LPL[S]","volume":"58","author":"Larsson","year":"2017","journal-title":"J Lipid Res"},{"issue":"23","key":"10.1016\/j.numecd.2025.104280_bib23","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1056\/NEJMoa1400284","article-title":"Targeting APOC3 in the familial chylomicronemia syndrome","volume":"371","author":"Gaudet","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.numecd.2025.104280_bib24","doi-asserted-by":"crossref","unstructured":"Huang Y., Mahley R.W. Apolipoprotein E: structure and function in lipid metabolism, neurobiology, and alzheimer\u2019s diseases. Neurobiol Dis 2014;72:3\u201312. doi:10.1016\/j.nbd.2014.08.025.","DOI":"10.1016\/j.nbd.2014.08.025"},{"issue":"4","key":"10.1016\/j.numecd.2025.104280_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174660","article-title":"Quantification of intrapancreatic fat in type 2 diabetes by MRI","volume":"12","author":"Al-Mrabeh","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.numecd.2025.104280_bib27","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology solution set oversight committee","volume":"78","author":"Virani","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.numecd.2025.104280_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12967-018-1755-5","article-title":"Serum protein signature of coronary artery disease in type 2 diabetes mellitus","volume":"17","author":"Adela","year":"2019","journal-title":"J Transl Med"},{"issue":"3","key":"10.1016\/j.numecd.2025.104280_bib29","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3390\/biom13030401","article-title":"Role of altered metabolism of triglyceride-rich lipoprotein particles in the development of vascular dysfunction in systemic lupus erythematosus","volume":"13","author":"Di\u00f3szegi","year":"2023","journal-title":"Biomolecules"},{"issue":"4","key":"10.1016\/j.numecd.2025.104280_bib30","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s00592-014-0567-1","article-title":"Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level","volume":"51","author":"Fendler","year":"2014","journal-title":"Acta Diabetol"},{"issue":"2","key":"10.1016\/j.numecd.2025.104280_bib31","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.ssresearch.2009.01.004","article-title":"Last-observation-carried-forward (LOCF) and tests for difference in mean rates of change in controlled repeated measurements designs with dropouts","volume":"38","author":"Overall","year":"2009","journal-title":"Soc Sci Res"},{"issue":"18","key":"10.1016\/j.numecd.2025.104280_bib32","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1001\/jama.2015.15281","article-title":"Multiple imputation: a flexible tool for handling missing data","volume":"314","author":"Li","year":"2015","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.numecd.2025.104280_bib33","first-page":"1322","article-title":"Missing data in clinical research: a tutorial on multiple imputation","volume":"37","author":"Austin","year":"2021","journal-title":"Can J Cardiol"},{"issue":"4","key":"10.1016\/j.numecd.2025.104280_bib34","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1172\/JCI117151","article-title":"Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice","volume":"93","author":"Shachter","year":"1994","journal-title":"J Clin Investig"},{"issue":"2","key":"10.1016\/j.numecd.2025.104280_bib35","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/MED.0000000000000136","article-title":"ApoC-III: a potent modulator of hypertriglyceridemia and cardiovascular disease","volume":"22","author":"Kohan","year":"2015","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"41","key":"10.1016\/j.numecd.2025.104280_bib36","doi-asserted-by":"crossref","first-page":"26388","DOI":"10.1074\/jbc.273.41.26388","article-title":"Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia","volume":"273","author":"Huang","year":"1998","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.numecd.2025.104280_bib37","article-title":"Fateful fat: Intra-pancreatic lipids cause pancreatic cancer. Cell reports","volume":"5","author":"Petrov","year":"2024","journal-title":"Medicine"},{"issue":"6","key":"10.1016\/j.numecd.2025.104280_bib38","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.2337\/db21-0976","article-title":"Fat distribution within the pancreas according to diabetes status and insulin traits","volume":"71","author":"Skudder-Hill","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/j.numecd.2025.104280_bib39","doi-asserted-by":"crossref","first-page":"6653857","DOI":"10.1155\/2024\/6653857","article-title":"Pancreatitis as a main consequence of APOC2-Related hypertriglyceridemia: the role of nonsense and frameshift variants","volume":"2024","author":"Rabbani","year":"2024","journal-title":"Int J Genomics"},{"key":"10.1016\/j.numecd.2025.104280_bib40","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12944-015-0171-6","article-title":"A novel APOC2 gene mutation identified in a Chinese patient with severe hypertriglyceridemia and recurrent pancreatitis","volume":"15","author":"Jiang","year":"2016","journal-title":"Lipids Health Dis"},{"issue":"7","key":"10.1016\/j.numecd.2025.104280_bib41","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2468-1253(23)00064-X","article-title":"Fatty change of the pancreas: the Pandora's box of pancreatology","volume":"8","author":"Petrov","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"8","key":"10.1016\/j.numecd.2025.104280_bib42","first-page":"989","article-title":"Apoc2 loss-of-function zebrafish mutant as a genetic model of hyperlipidemia","volume":"8","author":"Liu","year":"2015","journal-title":"Dis Model Mech"},{"issue":"25","key":"10.1016\/j.numecd.2025.104280_bib43","doi-asserted-by":"crossref","first-page":"23027","DOI":"10.1074\/jbc.M300315200","article-title":"Identification of a lipoprotein lipase cofactor-binding site by chemical cross-linking and transfer of apolipoprotein C-II-responsive lipolysis from lipoprotein lipase to hepatic lipase","volume":"278","author":"McIlhargey","year":"2003","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.numecd.2025.104280_bib44","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1124\/jpet.115.229740","article-title":"Creation of apolipoprotein C-II (ApoC-II) mutant mice and correction of their hypertriglyceridemia with an ApoC-II mimetic peptide","volume":"356","author":"Sakurai","year":"2016","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"2","key":"10.1016\/j.numecd.2025.104280_bib45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1124\/jpet.114.220418","article-title":"A novel apolipoprotein C-II mimetic peptide that activates lipoprotein lipase and decreases serum triglycerides in apolipoprotein E\u2013Knockout mice","volume":"352","author":"Amar","year":"2015","journal-title":"J Pharmacol Exp Therapeut"},{"issue":"528","key":"10.1016\/j.numecd.2025.104280_bib46","doi-asserted-by":"crossref","first-page":"eaaw7905","DOI":"10.1126\/scitranslmed.aaw7905","article-title":"A dual apolipoprotein C-II mimetic\u2013apolipoprotein C-III antagonist peptide lowers plasma triglycerides","volume":"12","author":"Wolska","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.numecd.2025.104280_bib47","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-025-06464-w","article-title":"ApoC-III and ectopic fat accumulation in individuals with type 2 diabetes: an exploratory analysis from the MEDEA randomised controlled study","author":"Costabile","year":"20256892036","journal-title":"Diabetologia"},{"issue":"6","key":"10.1016\/j.numecd.2025.104280_bib48","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00125-005-1753-z","article-title":"Alterations of lipids and apolipoprotein CIII in very low density lipoprotein subspecies in type 2 diabetes","volume":"48","author":"Hiukka","year":"2005","journal-title":"Diabetologia"},{"issue":"3","key":"10.1016\/j.numecd.2025.104280_bib49","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/MOL.0000000000000502","article-title":"Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism","volume":"29","author":"Ramms","year":"2018","journal-title":"Curr Opin Lipidol"},{"issue":"10","key":"10.1016\/j.numecd.2025.104280_bib50","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1172\/JCI35206","article-title":"Molecular processes that handle \u2014 and mishandle \u2014 dietary lipids","volume":"118","author":"Williams","year":"2008","journal-title":"J Clin Investig"},{"issue":"8","key":"10.1016\/j.numecd.2025.104280_bib51","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.1172\/JCI86610","article-title":"ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors","volume":"126","author":"Gordts","year":"2016","journal-title":"J Clin Investig"},{"issue":"19","key":"10.1016\/j.numecd.2025.104280_bib52","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160607","article-title":"Postprandial metabolism of apolipoproteins B48, B100, C-III, and E in humans with APOC3 loss-of-function mutations","volume":"7","author":"Taskinen","year":"2022","journal-title":"JCI insight"},{"issue":"1","key":"10.1016\/j.numecd.2025.104280_bib53","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/ATVBAHA.118.311476","article-title":"Effects of APOC3 heterozygous deficiency on plasma lipid and lipoprotein metabolism","volume":"39","author":"Reyes-Soffer","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"7","key":"10.1016\/j.numecd.2025.104280_bib54","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.metabol.2011.12.002","article-title":"A review of the role of apolipoprotein C-II in lipoprotein metabolism and cardiovascular disease","volume":"61","author":"Kei","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.numecd.2025.104280_bib55","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.orcp.2024.01.002","article-title":"Associations of pancreas fat content and size with markers of iron metabolism","volume":"18","author":"Kimita","year":"2024","journal-title":"Obes Res Clin Pract"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532500434X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S093947532500434X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T12:46:39Z","timestamp":1766580399000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S093947532500434X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S093947532500434X"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104280","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interplay between intra-pancreatic fat deposition, exchangeable apolipoproteins, and lipoprotein subclasses","name":"articletitle","label":"Article Title"},{"value":"Nutrition, Metabolism and Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.numecd.2025.104280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of The Italian Diabetes Society, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition and the Department of Clinical Medicine and Surgery, Federico II University.","name":"copyright","label":"Copyright"}],"article-number":"104280"}}